Engineering Functional CCR8 Antibodies to Advance Differentiated Immuno-Oncology Therapies
3:00 pm - Thursday 4th March 2027
- Demonstrating how functional characterization can identify GPCR-targeting antibodies with differentiated biological activity
- Leveraging translational biomarker strategies to validate target engagement and support clinical development
- Showcasing the development of a CCR8-targeting antibody program designed to overcome immunosuppressive mechanisms in solid tumors
